In the last trading session, 2.37 million shares of the Tenaya Therapeutics Inc (NASDAQ:TNYA) were traded, and its beta was 2.94. Most recently the company’s share price was $0.64, and it changed around -$0.02 or -2.82% from the last close, which brings the market valuation of the company to $103.50M. TNYA currently trades at a discount to its 52-week high of $5.32, offering almost -731.25% off that amount. The share price’s 52-week low was $0.39, which indicates that the current value has risen by an impressive 39.06% since then. We note from Tenaya Therapeutics Inc’s average daily trading volume that its 10-day average is 6.54 million shares, with the 3-month average coming to 3.48 million.
Tenaya Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended TNYA as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Tenaya Therapeutics Inc is expected to report earnings per share of -0.21 for the current quarter.
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Instantly TNYA has showed a red trend with a performance of -2.82% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.7300 on recent trading dayincreased the stock’s daily price by 12.33%. The company’s shares are currently down -55.48% year-to-date, but still down -8.91% over the last five days. On the other hand, Tenaya Therapeutics Inc (NASDAQ:TNYA) is -43.66% down in the 30-day period. We can see from the shorts that 14.4 million shares have been sold at a short interest cover period of 8.63 day(s).
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -15.48%.
TNYA Dividends
Tenaya Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-Mar-09.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.42% of Tenaya Therapeutics Inc shares, and 106.82% of them are in the hands of institutional investors. The stock currently has a share float of 108.36%. Tenaya Therapeutics Inc stock is held by 120.0 institutions, with COLUMN GROUP LLC being the largest institutional investor. By 2024-06-30, it held 10.968% of the shares, which is about 9.4 million shares worth $29.14 million.
RA CAPITAL MANAGEMENT, L.P., with 8.8935% or 7.62 million shares worth $23.63 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
